Here Prox1 OE also reduced the number of tumor nodules (3.25 versus 19.5 nodules), all lacking Prox1-IRES-GFP, and extended survival from 26.5 to 47.5 days (Fig. 2k–m and Extended Data Fig. 4o,p). This evidence concerns the gene PROX1 and neoplasm.